(MENAFN- Straits Research)
Market Overview
The European tangential flow filtration market size was valued at USD 1.28 billion in 2025 and is projected to grow from USD 1.40 billion in 2026 to USD 2.85 billion by 2034 at a CAGR of 9.3% during the forecast period 2026-2034.
The biopharmaceutical and food industries make substantial use of a method of separation known as tangential flow filtration (TFF), which is also known as crossflow filtration. Tangential flow filtration (TFF) is different from other filtration systems in that the liquid is moved onward parallel to the filter. This is done rather than the liquid being thrust by way of a membrane perpendicularly, which can congest the filter media. Tangential flow filtration (TFF) was developed in the 1970s. In the past, the process of creating a membrane filter consisted of installing a porous membrane in such a way that it was positioned perpendicularly across the course of a liquid mixture from which a certain species was to be extracted. The selected species is held back by the membrane while the fluid mixture travels through the membrane and passes through it. Polyether sulfone (PES) membranes have shown greater viral permeation effectiveness than polyvinylidene difluoride (PVDF) membranes in bacteria-size membranes, despite the fact that polyvinylidene difluoride (PVDF) membranes have shown greater bacterial restoration. This is true regardless of the environment or the scale of the TFF. Both reverse osmosis (RO) and nanofiltration (NF) are types of TFF. In both of these processes, highly compact membranes are used to separate salts and very small molecules from water or other solvents. The molecular weights of these salts and molecules are typically lower than 1500 Daltons. Microfiltration, abbreviated as MF, is a technique that is frequently used upstream in a restoration method. Its purpose is to separate intact cells and a small amount of cell debris or lysates from the other components in the input stream. The Europe Tangential Flow Filtration Market is anticipated to be driven by the several advantages of tangential flow filtration in comparison to conventional flow filtration.
Download a Free Sample To learn more about this report,
Market Dynamics
Drivers
The expansion of capabilities among pharmaceutical businesses is a primary force behind the expansion of the industry in Europe. The rising costs of research and development incurred by biotechnology and pharmaceutical businesses, in addition to a rise in the number of biologics and CMOs, are further driving up market demand. The expansion of the market is being driven in part by the rising prevalence of one-time use technologies in the pharmaceutical sector. Demand in the market is growing as a result of the wide variety of applications that can be found in the field of biologics. The expansion of the healthcare infrastructure brought about by the rise in technical breakthroughs and the presence of an intellectual property system for the manufacture of novel biological products are the primary factors driving the growth of the FF market.
Restraints
It is anticipated that stringent regulations imposed by the government in order to approve of new technology would impede the expansion of the industry. One further thing that is holding back market demand is the enormous sum of money that is needed to get the unique production services up and running.
Segmentation Analysis
By Type
The Europe tangential flow filtration market is segmented into Single-Use Tangential Flow Filtration Systems, Reusable Tangential Flow Filtration Systems, Filtration Accessories, and Membrane Filters. Single-use systems are increasingly adopted in biopharmaceutical processing due to their convenience and reduced cleaning requirements, while reusable systems remain important for established processing operations.
Membrane filters and filtration accessories support filtration systems by enabling separation and process integration. Growing biopharmaceutical manufacturing, particularly in areas such as biologics and advanced therapies, is supporting demand for TFF equipment and consumables across Europe.
Request Customization to receive a tailored report.
By Technology
The market is segmented into Ultrafiltration, Microfiltration, Reverse Osmosis, and Nanofiltration. Ultrafiltration is widely used for concentrating and purifying macromolecules, while microfiltration supports separation of larger particles and biological materials. Nanofiltration provides finer molecular separation, and reverse osmosis is used for high-level separation through semipermeable membranes.
Ultrafiltration remains an important technology for biopharmaceutical concentration and diafiltration processes, while microfiltration is gaining importance in applications such as sterile filtration and cell processing. Increasing adoption of advanced bioprocessing technologies is supporting demand for these filtration methods across Europe.
Speak to an Analyst to discuss market opportunities.
Regional Analysis
The market is now being led by the United Kingdom, which holds the largest share. The significant presence of important competitors and pharmaceutical corporations is having a positive impact on the expansion of the industry. The growth of the Europe tangential flow filtration market is helped along by increasing levels of government funding and investments in the introduction of new products. Germany is in second place behind the UK in terms of the FF market. Demand in this country's market is significantly increasing as a result of rising levels of discretionary income in metropolitan regions.
List of Key and Emerging Players in Europe Tangential Flow Filtration Market
Merck KGaA
Novasep Holding SAS
Solaris Biotechnology SRL
Sartorius AG
Key Industry Developments
May 2026: Sartorius Stedim Biotech inaugurated a new Competence Center in Freiburg, Germany, investing more than EUR 140 million to expand the development and production of critical materials for cell and gene therapy manufacturing, strengthening Europe's bioprocessing infrastructure supporting tangential flow filtration applications.
April 2026: Repligen Corporation opened a new European Training & Innovation Center in Breda, Netherlands, expanding customer training, process development, and technical support capabilities for bioprocessing technologies, including tangential flow filtration systems.
September 2025: Yokogawa Electric Corporation and Repligen Corporation entered into a strategic partnership to integrate process analytical technology (PAT) with advanced bioprocessing solutions, enhancing automation and real-time monitoring for downstream manufacturing processes, including tangential flow filtration.
Report Scope
Comments
No comment